Loading clinical trials...
Loading clinical trials...
A Phase II, Single Centre, Randomised, Placebo-controlled, 3-part Trial to Assess the Safety, Tolerability and Efficacy of Zibotentan in Patients With Renal Disease Secondary to Scleroderma
Conditions
Interventions
Zibotentan
Locations
1
United Kingdom
Royal Free London NHS Foundation Trust
London, United Kingdom
Start Date
October 1, 2014
Primary Completion Date
October 1, 2017
Completion Date
October 1, 2017
Last Updated
October 31, 2017
NCT07241390
NCT06926660
NCT07470151
NCT06717698
NCT07450820
NCT06306963
Lead Sponsor
University College, London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions